Tumor-immune trajectory context connects static tissue architecture to clinical outcomes
Eric M. Cramer, Randy W. Heiland, Heber Lima da Rocha…·Young Hwan Chang
This paper introduces a trajectory-centric framework to model dynamic tumor-immune interactions, showing that treatment-phase TME states predict immunotherapy response better than pre-treatment states.